Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Do national cancer control plans address care and research for children, adolescents, and young adults? A review of status, priorities, and recommendations across 41 European countries.
Prades J, Kozhaeva O, Otth M, Kearns P, Ladenstein R, Rizzari C, Heenen D, Dirksen U, Owens C, Lazarov D, Sheehan C, Borras JM, Vassal G. Prades J, et al. Among authors: rizzari c. Lancet Reg Health Eur. 2024 Dec 18;49:101155. doi: 10.1016/j.lanepe.2024.101155. eCollection 2025 Feb. Lancet Reg Health Eur. 2024. PMID: 39807152 Free PMC article. Review.
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis.
Di Majo BE, Vendemini F, Bonanomi S, Casartelli P, Napolitano S, Ottaviano G, Prunotto G, Verna M, Sala A, Migliorino GM, Petrella F, Rosso L, Claut L, Rafaniello Raviele P, Rizzari C, Biondi A, Balduzzi A, Lucchini G. Di Majo BE, et al. Among authors: rizzari c. Tumori. 2024 Dec 17:3008916241301912. doi: 10.1177/03008916241301912. Online ahead of print. Tumori. 2024. PMID: 39688204
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.
Bielack SS, Soussain C, Fox CP, Houillier C, Murciano T, Osborne W, Zinzani PL, Rizzari C, Schwartz S. Bielack SS, et al. Among authors: rizzari c. J Cancer Res Clin Oncol. 2024 Oct 2;150(10):441. doi: 10.1007/s00432-024-05945-6. J Cancer Res Clin Oncol. 2024. PMID: 39356310 Free PMC article. Review.
Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.
Peters C, Bruno A, Rizzari C, Brescianini A, Von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F. Peters C, et al. Among authors: rizzari c. Haematologica. 2025 Jan 1;110(1):234-238. doi: 10.3324/haematol.2024.285837. Haematologica. 2025. PMID: 39234873 Free PMC article. No abstract available.
Retrospective comparative analysis of two medical evacuation systems for Ukrainian patients affected by war.
Mueller A, Salek M, Oszer A, Evseev D, Yakimkova T, Wlodarski M, Vinitsky A, Kizyma R, Pogorelyy M, Zuber M, Escalante J, Lipska E, Fendler W, Nowicka Z, Szyszka A, Kacharian A, Rodriguez-Galindo C, Wise PH, Agulnik A, Mlynarski W; SAFER Ukraine collaborative. Mueller A, et al. Eur J Cancer. 2024 Oct;210:114271. doi: 10.1016/j.ejca.2024.114271. Epub 2024 Aug 8. Eur J Cancer. 2024. PMID: 39232428 Free article.
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.
Wu JH, Pennesi E, Bautista F, Garrett M, Fukuhara K, Brivio E, Ammerlaan ACJ, Locatelli F, van der Sluis IM, Rossig C, Chen-Santel C, Bielorai B, Petit A, Starý J, Díaz-de-Heredia C, Rives S, O'Marcaigh A, Rizzari C, Engstler G, Nysom K, Rubio-San-Simón A, Bruno B, Bertrand Y, Brethon B, Rialland F, Plat G, Dirksen U, Sramkova L, Zwaan CM, Huitema ADR. Wu JH, et al. Among authors: rizzari c. Clin Pharmacokinet. 2024 Jul;63(7):981-997. doi: 10.1007/s40262-024-01386-z. Epub 2024 Jun 22. Clin Pharmacokinet. 2024. PMID: 38907948 Free PMC article.
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target.
Taurino G, Dander E, Chiu M, Pozzi G, Maccari C, Starace R, Silvestri D, Griffini E, Bianchi MG, Carubbi C, Andreoli R, Mirandola P, Valsecchi MG, Rizzari C, D'Amico G, Bussolati O. Taurino G, et al. Among authors: rizzari c. Br J Haematol. 2024 Jul;205(1):175-188. doi: 10.1111/bjh.19516. Epub 2024 May 13. Br J Haematol. 2024. PMID: 38736325
Demographic Analysis of Cancer Research Priorities and Treatment Correlations.
Horgan D, Van den Bulcke M, Malapelle U, Normanno N, Capoluongo ED, Prelaj A, Rizzari C, Stathopoulou A, Singh J, Kozaric M, Dube F, Ottaviano M, Boccia S, Pravettoni G, Cattaneo I, Malats N, Buettner R, Lekadir K, de Lorenzo F, Alix-Panabieres C, Badreh S, Solary E, De Maria R, Hofman P. Horgan D, et al. Among authors: rizzari c. Curr Oncol. 2024 Mar 29;31(4):1839-1864. doi: 10.3390/curroncol31040139. Curr Oncol. 2024. PMID: 38668042 Free PMC article.
176 results